Enhancement of in-Vitro GC Function in Patients With COPD

NCT00241631 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

49

Enrollment

OTHER

Sponsor class

Conditions

COPD

Interventions

DRUG: Fluticasone Propionate
DRUG: placebo
DRUG: Theophylline

Sponsor

Imperial College London

Collaborators

[object Object]
[object Object]